Printer Friendly
The Free Library
14,680,088 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Neuromodulation Systems Completes Acquisition of Hi-tronics Designs.


Business Editors

DALLAS--(BUSINESS WIRE)--Jan. 3, 2001

Advanced Neuromodulation Systems Inc. (ANS (ANS Communications, Inc, Purchase, NY) An ISP, Internet backbone and provider of private data network services, founded in 1990 as Advanced Network & Services, Inc., by IBM, MCI and Merit (consortium of Michigan universities). ) (Nasdaq:ANSI (American National Standards Institute, New York, www.ansi.org) A membership organization founded in 1918 that coordinates the development of U.S. voluntary national standards in both the private and public sectors. It is the U.S. member body to ISO and IEC. ) today announced that it has completed the previously announced acquisition of Hi-tronics Designs Inc. (HDI HDI Human Development Index (UNDP yardstick of human welfare)
HDI Help Desk Institute
HDI Humpty Dumpty Institute (New York, New York)
HDI High Density Interconnect
), a privately held contract developer and original equipment manufacturer (OEM) of electro-mechanical devices headquartered in Budd Lake, N.J.

ANS acquired all of HDI's outstanding stock through a merger in exchange for 1.1 million shares of ANS common stock.

HDI developed and will supply ANS's Totally Implantable Pulse Generator implantable pulse generator Cardiac pacing A pacemaker used for permanent pacing, which is placed inside a pocket under the skin; the leads are positioned in or on the heart  (IPG IPG Implantable pulse generator, see there ) and is the manufacturer of the transmitter used with ANS's Renew radio frequency (RF) neurostimulation system. HDI has developed more than 30 medical devices for leading device companies, including Medtronic Inc. (NYSE NYSE

See: New York Stock Exchange
:MDT), Cyberonics (Nasdaq:CYBX), Orthofix International N.V. (Nasdaq:OFIX), Exogen (now part of Smith & Nephew plc) and Micromed Technology Inc., and its technology has been instrumental in the success of a number of new public medical device companies.

The transaction will be accounted for on a "pooling of interests Pooling of Interests

An accounting method, used in mergers and acquisitions, where the balance sheet items of the two companies are simply added together.

Notes:
The opposite of pooling of interests is the purchase acquisition method.
" basis. ANS expects to record a charge for transaction-related expenses in the first quarter ending March 31, 2001. Exclusive of this charge, the transaction is expected to be accretive to ANS's earnings on a fully diluted basis in calendar year 2001.

About Advanced Neuromodulation Systems

Advanced Neuromodulation Systems designs, develops, manufactures and markets implantable systems used to manage chronic intractable pain and other disorders of the central nervous system.

The following is a "safe harbor" statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

Statements contained in this document that are not based on historical facts are "forward-looking statements." Terms such as "plan," "should," "would," "anticipate," "believe," "intend," "estimate," "expect," "predict," "scheduled," "new market," "potential market applications" and similar expressions are intended to identify forward-looking statements. Such statements are by nature subject to uncertainties and risks, including but not limited to: completion of research and development projects in an efficient and timely manner; obtaining regulatory approvals on a timely and cost-efficient basis to permit the introduction of new products; the satisfactory completion of clinical trials and/or market tests prior to the introduction of new products; the adequacy, acceptability and timeliness of component supply; the approval of new products by reimbursement agencies including insurance companies, HMOs, Medicare and Medicaid Medicare and Medicaid

U.S. government programs in effect since 1966. Medicare covers most people 65 or older and those with long-term disabilities. Part A, a hospital insurance plan, also pays for home health visits and hospice care.
; the efficacy of the Company's products for new applications; and other risks detailed from time to time in the Company's SEC filings. Consequently, if such management assumptions prove to be incorrect or such risks or uncertainties materialize, anticipated results could differ materially from those forecast in forward-looking statements.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 3, 2001
Words:421
Previous Article:Jacob Cherian Named Vice President, Corporate Controller of SL Industries Inc.
Next Article:Rock of Ages Completes Acquisition of 16 Cemeteries in Kentucky.
Topics:



Related Articles
Semco. (Acquisitions, Expansions) (Brief Article)
Advanced Neuromodulation Systems To Acquire Hi-tronics Designs, Inc.
Advanced Neuromodulation Systems Announces Denial of IPG Reclassification by The FDA.
Advanced Neuromodulation Systems Announces Fourth-Quarter and 2000 Results.
Advanced Neuromodulation Systems Announces First-Quarter Results.
Advanced Neuromodulation Systems Reports Record Second Quarter Revenue.
Advanced Neuromodulation Systems Names General Counsel and EVP - Corporate Development.
Advanced Neuromodulation Systems Fourth Quarter Net Income Increases to $0.07 Per Diluted Share From $0.01 As Revenue Increases 33% to a Record $10.5...
Advanced Neuromodulation Systems Prices Public Offering of 2,500,000 Shares of Common Stock.
Advanced Neuromodulation Systems Reports Record First Quarter Results; Net Income Increases 51% on 46% Increase in Neuro Sales.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles